| Title : Impact of study design and patient population on outcomes from cholinesterase inhibitor trials - Anand_2003_Am.J.Geriatr.Psychiatry_11_160 |
| Author(s) : Anand R , Hartman R , Sohn H , Danyluk J , Graham SM |
| Ref : American Journal of Geriatry & Psychiatry , 11 :160 , 2003 |
| Abstract : |
| PubMedSearch : Anand_2003_Am.J.Geriatr.Psychiatry_11_160 |
| PubMedID: 12611745 |
| Title : A pilot, randomized, open-label trial assessing safety and pharmakokinetic parameters of co-administration of rivastigmine with risperidone in dementia patients with behavioral disturbances - Weiser_2002_Int.J.Geriatr.Psychiatry_17_343 |
| Author(s) : Weiser M , Rotmensch HH , Korczyn AD , Hartman R , Cicin-Sain A , Anand R |
| Ref : Int J Geriatr Psychiatry , 17 :343 , 2002 |
| Abstract : |
| PubMedSearch : Weiser_2002_Int.J.Geriatr.Psychiatry_17_343 |
| PubMedID: 11994888 |
| Title : Electrocardiographic effects of rivastigmine - Morganroth_2002_J.Clin.Pharmacol_42_558 |
| Author(s) : Morganroth J , Graham S , Hartman R , Anand R |
| Ref : Journal of Clinical Pharmacology , 42 :558 , 2002 |
| Abstract : |
| PubMedSearch : Morganroth_2002_J.Clin.Pharmacol_42_558 |
| PubMedID: 12017350 |
| Title : Impact of Alzheimer's disease and rivastigmine treatment on activities of daily living over the course of mild to moderately severe disease - Potki_2002_Prog.Neuropsychopharmacol.Biol.Psychiatry_26_713 |
| Author(s) : Potki SG , Anand R , Hartman R , Veach J , Grossberg G |
| Ref : Prog Neuropsychopharmacol Biological Psychiatry , 26 :713 , 2002 |
| Abstract : |
| PubMedSearch : Potki_2002_Prog.Neuropsychopharmacol.Biol.Psychiatry_26_713 |
| PubMedID: 12188104 |
| Title : Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease - Potkin_2001_Int.J.Neuropsychopharmacol_4_223 |
| Author(s) : Potkin SG , Anand R , Fleming K , Alva G , Keator D , Carreon D , Messina J , Wu JC , Hartman R , Fallon JH |
| Ref : Int J Neuropsychopharmacol , 4 :223 , 2001 |
| Abstract : |
| PubMedSearch : Potkin_2001_Int.J.Neuropsychopharmacol_4_223 |
| PubMedID: 11602028 |
| Title : Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression - Farlow_2001_Arch.Neurol_58_417 |
| Author(s) : Farlow MR , Hake A , Messina J , Hartman R , Veach J , Anand R |
| Ref : Archives of Neurology , 58 :417 , 2001 |
| Abstract : |
| PubMedSearch : Farlow_2001_Arch.Neurol_58_417 |
| PubMedID: 11255445 |
| Title : An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors - Kumar_2000_Eur.J.Neurol_7_159 |
| Author(s) : Kumar V , Anand R , Messina J , Hartman R , Veach J |
| Ref : Eur Journal of Neurology , 7 :159 , 2000 |
| Abstract : |
| PubMedSearch : Kumar_2000_Eur.J.Neurol_7_159 |
| PubMedID: 10809936 |
| Title : A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease - Farlow_2000_Eur.Neurol_44_236 |
| Author(s) : Farlow M , Anand R , Messina J, Jr. , Hartman R , Veach J |
| Ref : Eur Neurol , 44 :236 , 2000 |
| Abstract : |
| PubMedSearch : Farlow_2000_Eur.Neurol_44_236 |
| PubMedID: 11096224 |
| Title : Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial - Rosler_1999_BMJ_318_633 |
| Author(s) : Rosler M , Anand R , Cicin-Sain A , Gauthier S , Agid Y , Dal-Bianco P , Stahelin HB , Hartman R , Gharabawi M |
| Ref : BMJ , 318 :633 , 1999 |
| Abstract : |
| PubMedSearch : Rosler_1999_BMJ_318_633 |
| PubMedID: 10066203 |